Compared to the lymphoma group, the LGBLEL group exhibited higher expression levels of CCL28, CXCL17, HCK, GNB5, NRAS, and VAV2 (p = 0.001, <0.001, <0.001, <0.001, 0.020, and <0.001, respectively) and lower expression of CCR1 (p = 0.002) (Figure 4). The gene discussed is CCL28; the disease is lymphoma.